GlassScriptPhysician profile
Joanne E Vogel
NPI 1194759274
$1,270.95
in general payments reported to CMS, 2019-2025
23 companies · $21.26 in 2025
The $21.26 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $387 · 2023: $366 · 2025: $21.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.71 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $218.19 | 2021-2023 | Ztlido |
| Pfizer INC. | $112.78 | 2023 | |
| Amgen INC. | $86.18 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $64.16 | 2021 | |
| Collegium Pharmaceutical, INC. | $58.30 | 2022-2023 | Belbuca |
| Biohaven Pharmaceutical Holding Company LTD. | $54.82 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.73 | 2021-2023 | Relistor |
| Neurocrine Biosciences, INC. | $34.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.24 | 2021 | |
| Biogen, INC. | $28.99 | 2023 | Avonex, Vumerity, Plegridy |
| Alfasigma USA, INC. | $22.80 | 2021 | |
| Uswm, LLC | $21.81 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.78 | 2023 | Horizant |
| Hikma Pharmaceuticals USA | $21.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $19.81 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.85 | 2021 | |
| Medtronic, INC. | $16.66 | 2022 | |
| Boston Scientific Corporation | $15.11 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.29 | 2022 | |
| Sunovion Pharmaceuticals INC. | $14.05 | 2021 | |
| Lilly USA, LLC | $12.66 | 2021 | |
| Nevro Corp. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.